Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05510531 · ClinicalTrials.gov registry record · NA

Diabetes Survival Skills + (DSS+) Training Intervention for Incarcerated Persons Transitioning to the Community (TTC)

A NA study, sponsored by University of Connecticut.

Completed
Registry status
NA
Development phase
92
Enrollment target

NCT05510531: Completed NA study, sponsored by University of Connecticut.

NCT05510531 is a NA study that has completed, run by University of Connecticut. The registered enrollment target is 92 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05510531, a NA study, has completed, sponsored by University of Connecticut.

COMPLETED
Registry status
NA
Development phase
92 participants
Enrollment target

Study Summary

The purpose was to examine the feasibility and acceptability of a Diabetes Survival Skills intervention training with and without a support group for incarcerated persons transitioning to the community. Feasibility will include limited efficacy testing to examine the effect of the DSS+ intervention on diabetes knowledge, self-efficacy, outcome expectancies, and diabetes-related distress.

Primary Outcome

measured by Spoken knowledge for Low Literacy in Diabetes (SKILLD) , a 10-item scale that measures diabetes knowledge e.g. medication taking, blood glucose monitoring

Interventions

  • BEHAVIORAL Diabetes Survival Skills Training

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2017-03-08
Est. Completion 2019-01-10
Phase NA
University of Connecticut

107 total trials

What the finished NCT05510531 record still lists

NCT05510531 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which Diabetes Survival Skills Training is the first listed.

NCT05510531 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05510531 about?

NCT05510531 is a clinical study titled "Diabetes Survival Skills + (DSS+) Training Intervention for Incarcerated Persons Transitioning to the Community (TTC)". The purpose was to examine the feasibility and acceptability of a Diabetes Survival Skills intervention training with and without a support group for incarcerated persons transitioning to the community. Feasibility will include limited efficacy testing to examine the effect of the DSS+ intervention ...

What is the current status of trial NCT05510531?

This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2017-03-08. Estimated completion is 2019-01-10.

What interventions are being tested in trial NCT05510531?

The interventions under investigation include: Diabetes Survival Skills Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT05510531?

This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05510531's enrollment target sits among peer trials

92 937th of 2000 higher than 1,062 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03184545 · 92 participants · Phase 3

    Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome

  • NCT04172532 · 92 participants · Phase 1

    Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

  • NCT04508088 · 92 participants

    Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease

  • NCT04840602 · 92 participants · Phase 2

    Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05510531, the US trial registry maintained by the National Library of Medicine. NCT05510531 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.